Cotransfection O
of O
Ets B
- I
2 I
and O
p44 B
mitogen B
- I
activated I
protein I
( I
MAP I
) I
kinase I
expression O
vectors O
strongly O
potentiated O
HB B
- O
EGF B
promoter O
activation O
in O
response O
to O
deltaRaf B
- I
1 I
: O
ER B
. O

Inactivity O
of O
the O
human B
cytomegalovirus I
( I
HCMV I
) I
major I
immediate I
- I
early I
regulatory I
region I
( O
MIERR B
) O
, O
which O
is O
composed O
of O
promoter O
, O
enhancer O
, O
unique O
region O
, O
and O
modulator O
, O
is O
linked O
to O
lack O
of O
HCMV O
replication O
in O
latently O
infected O
cells O
and O
in O
other O
nonpermissive O
cell O
types O
, O
including O
human O
embryonal O
NTera2 O
carcinoma O
( O
NT2 O
) O
cells O
. O

For O
this O
purpose O
, O
we O
used O
a O
series O
of O
plasmid O
constructs O
encoding O
different O
forms O
of O
the O
envelope B
glycoprotein I
E I
of I
the I
flavivirus I
tick I
- I
borne I
encephalitis I
virus I
. O

In O
order O
to O
examine O
the O
potential O
role O
of O
transcriptional O
silencing O
during O
productive O
HSV O
- O
1 O
infection O
, O
recombinant O
viruses O
were O
generated O
in O
which O
wild B
- I
type I
or I
mutant I
ICP34 I
. I
5 I
promoters I
controlling O
the O
expression O
of O
a O
chloramphenicol B
acetyltransferase I
reporter I
gene I
were O
inserted O
into O
the O
thymidine B
kinase I
gene I
of O
the O
viral O
genome O
. O

ME1a1 B
, O
a O
16 O
- O
base O
- O
pair O
nuclear O
factor O
binding O
site O
residing O
between O
the O
c B
- I
MYC I
P1 I
and I
P2 I
transcription I
initiation I
sites I
, O
is O
required O
for O
P2 O
activity O
. O

The O
galactose B
transporter I
shows O
both O
sequence O
and O
structural O
homology O
with O
a O
superfamily O
of O
sugar B
transporters I
which O
includes O
the O
human B
HepG2 I
- I
erythrocyte I
and I
fetal I
muscle I
glucose I
transporters I
, O
the O
rat B
brain I
and I
liver I
glucose I
transporters I
, O
the O
Escherichia B
coli I
xylose I
and I
arabinose I
permeases I
, O
and O
the O
S B
. I
cerevisiae I
glucose I
, I
maltose I
, I
and I
galactose I
transporters I
. O

The O
galactose B
transporter I
shows O
both O
sequence O
and O
structural O
homology O
with O
a O
superfamily O
of O
sugar B
transporters I
which O
includes O
the O
human B
HepG2 I
- I
erythrocyte I
and I
fetal I
muscle I
glucose I
transporters I
, O
the O
rat B
brain I
and I
liver I
glucose I
transporters I
, O
the O
Escherichia B
coli I
xylose I
and I
arabinose I
permeases I
, O
and O
the O
S B
. I
cerevisiae I
glucose I
, I
maltose I
, I
and I
galactose I
transporters I
. O

Members O
of O
the O
myocyte B
- I
specific I
enhancer I
- I
binding I
factor I
2 I
( O
MEF2 B
) O
family O
of O
transcription O
factors O
bind O
a O
conserved O
A O
/ O
T O
- O
rich O
sequence O
in O
the O
control O
regions O
of O
numerous O
muscle O
- O
specific O
genes O
. O

Dilutions O
of O
H B
- I
2b I
or I
H I
- I
2d I
NP I
peptides I
indicated O
that O
3 O
- O
4 O
logs O
less O
H B
- I
2b I
NP I
peptide I
was O
required O
to O
sensitize O
syngeneic O
target O
cells O
for O
CTL O
- O
specific O
lysis O
, O
suggesting O
that O
the O
differing O
affinities O
of O
H O
- O
2b O
and O
H O
- O
2d O
major B
histocompatibility I
complex I
molecules I
for O
their O
peptides O
likely O
account O
for O
the O
total O
removal O
of O
NP O
CTL O
in O
the O
H O
- O
2b O
mice O
but O
only O
partial O
removal O
in O
H O
- O
2d O
mice O
made O
to O
express O
thymic O
NP O
. O

Amino O
acid O
sequence O
comparison O
revealed O
significant O
homology O
between O
the O
yeast B
and I
Escherichia I
coli I
gamma I
- I
glutamyl I
kinases I
throughout O
their O
lengths O
. O

Vasoactive B
intestinal I
peptide I
and O
pituitary B
adenylate I
cyclase I
- I
activating I
polypeptide I
inhibit O
nuclear B
factor I
- I
kappa I
B I
- I
dependent I
gene I
activation O
at O
multiple O
levels O
in O
the O
human O
monocytic O
cell O
line O
THP O
- O
1 O
. O

The O
RNA O
- O
binding O
and O
RNA B
- I
DNA I
helicase I
activities O
of O
the O
Escherichia B
coli I
transcription I
termination I
factor I
rho I
have O
been O
investigated O
using O
natural O
RNA O
molecules O
that O
are O
255 O
and O
391 O
nucleotide O
residues O
in O
length O
and O
that O
contain O
the O
trp B
t I
' I
rho I
- I
dependent I
termination I
sequence I
of O
E O
. O
coli O
. O

Previous O
work O
has O
shown O
that O
spleen B
necrosis I
virus I
( I
SNV I
) I
long I
terminal I
repeats I
( O
LTRs O
) O
are O
associated O
with O
Rex B
/ O
Rex B
- O
responsive O
element O
- O
independent O
expression O
of O
bovine O
leukemia O
virus O
RNA O
and O
supports O
the O
hypothesis O
that O
SNV O
RNA O
contains O
a O
cis O
- O
acting O
element O
that O
interacts O
with O
cellular B
Rex I
- I
like I
proteins I
. O

RANTES B
( O
regulated B
upon I
activation I
, I
normally I
T I
- I
cell I
expressed I
and I
presumably I
secreted I
) O
is O
a O
CC O
chemokine O
which O
recruits O
and O
activates O
monocytes O
, O
lymphocytes O
, O
and O
eosinophils O
, O
all O
cell O
types O
present O
in O
the O
lung O
inflammatory O
infiltrate O
induced O
by O
RSV O
infection O
. O

The O
class B
II I
Escherichia I
coli I
alanine I
tRNA I
synthetase I
aminoacylates I
RNA I
miniduplexes I
, O
which O
reconstruct O
the O
acceptor O
end O
of O
alanine B
tRNA I
with O
the O
critical O
G3 O
: O
U70 O
base O
pair O
. O

Isolation O
of O
cDNAs B
encoding I
gibbon I
and I
monkey I
platelet I
and I
T I
cell I
activation I
antigen I
1 I
( O
PTA1 B
) O
. O

Expression O
of O
the O
human O
T B
cell I
receptor I
( I
TCR I
) I
alpha I
gene I
is O
regulated O
by O
a O
T O
cell O
- O
specific O
transcriptional O
enhancer O
that O
is O
located O
4 O
. O
5 O
kilobases O
( O
kb O
) O
3 O
' O
to O
the O
C B
alpha I
gene I
segment I
. O

Among O
six O
different O
library O
isolates O
containing O
6 B
. I
5 I
- I
to I
7 I
- I
kb I
IAP I
units I
, O
some O
restriction O
sites O
were O
highly O
conserved O
whereas O
others O
varied O
in O
both O
occurrence O
and O
position O
. O

Seven O
clones O
encoding O
interferon B
response I
element I
binding I
factors I
have O
been O
isolated O
from O
a O
mouse O
fibroblast O
lambda O
gt11 O
cDNA O
library O
by O
using O
a O
32P O
end O
- O
labeled O
tandem O
trimer O
of O
the O
mouse B
( I
2 I
' I
- I
5 I
' I
) I
oligoadenylate I
synthetase I
gene I
interferon O
response O
element O
as O
a O
probe O
. O

The O
human B
cytomegalovirus I
( I
HCMV I
) I
major I
immediate I
- I
early I
protein I
IE2 I
is O
a O
nuclear O
phosphoprotein O
that O
is O
believed O
to O
be O
a O
key O
regulator O
in O
both O
lytic O
and O
latent O
infections O
. O

A O
2 B
. I
4 I
- I
kb I
MAPKAPK I
- I
2 I
message I
is O
expressed O
throughout O
development O
, O
while O
two O
shorter O
transcripts O
of O
2 O
. O
3 O
and O
1 O
. O
8 O
kb O
appear O
to O
be O
specifically O
expressed O
in O
the O
germline O
. O

Both O
strains O
grew O
very O
poorly O
, O
or O
not O
at O
all O
, O
on O
nonfermentable O
carbon O
sources O
and O
exhibited O
, O
at O
most O
, O
only O
5 O
% O
of O
wild B
- I
type I
ubiquinol I
- I
cytochrome I
c I
oxidoreductase I
activity O
. O

In O
addition O
, O
marked O
hypertension O
accompanied O
this O
disorder O
and O
all O
abnormalities O
, O
including O
the O
hypertension O
, O
responded O
to O
1 B
- I
desamino I
- I
8 I
- I
D I
- I
arginine I
vasopressin I
therapy O
. O

We O
found O
that O
both O
the O
E26 O
virus O
- O
encoded O
v B
- I
ets I
and O
the O
myeloid B
/ I
B I
- I
cell I
- I
specific I
factor I
PU I
. I
1 I
bind O
efficiently O
to O
this O
site O
in O
vitro O
. O

Self O
or O
foreign O
cellular O
proteins O
provide O
peptides O
for O
presentation O
by O
major B
histocompatibility I
complex I
( I
MHC I
) I
class I
I I
molecules I
on O
the O
surface O
of O
antigen O
presenting O
cells O
( O
APC O
) O
. O

In O
Experiment O
1 O
, O
pups O
that O
had O
received O
an O
injection O
of O
the O
noncompetitive O
N B
- I
methyl I
- I
D I
- I
aspartate I
receptor I
antagonist O
MK O
- O
801 O
( O
0 O
. O
1 O
mg O
/ O
kg O
, O
i O
. O
p O
. O
) O
either O
30 O
min O
before O
or O
immediately O
after O
conditioning O
spent O
less O
time O
over O
the O
conditioned O
odor O
than O
saline O
- O
treated O
controls O
. O

UDP B
- I
Gal I
: I
Gal I
beta I
1 I
- I
- I
- I
- I
4GlcNAc I
alpha I
1 I
- I
- I
- I
- I
3 I
- I
galactosyltransferase I
is O
a O
terminal B
glycosyltransferase I
that O
is O
widely O
expressed O
in O
a O
variety O
of O
mammalian O
species O
, O
with O
the O
notable O
exception O
of O
man O
, O
apes O
, O
and O
Old O
World O
monkeys O
. O

Insulin B
- I
like I
growth I
factor I
- I
binding I
protein I
- I
2 I
( O
IGF B
- I
BP I
- I
2 I
) O
transcription O
in O
rat O
liver O
varies O
with O
developmental O
age O
and O
fasting O
. O

The O
AGM B
and I
NIH I
/ I
Swiss I
mouse I
CCR5 I
proteins I
are O
97 O
. O
7 O
to O
98 O
. O
3 O
% O
and O
79 O
. O
8 O
% O
identical O
to O
the O
human O
protein O
, O
respectively O
. O

The O
promoter O
of O
the O
rat B
PGS I
- I
2 I
gene I
contains O
a O
CAAT B
enhancer I
- I
binding I
protein I
consensus I
site I
( I
CAAT I
box I
) I
which O
can O
confer O
hormone O
inducibility O
to O
a O
PGS B
- I
2 I
. O
CAT B
reporter O
gene O
, O
as O
well O
as O
a O
putative O
E O
- O
box O
region O
. O

The O
m7GpppN O
cap O
structure O
of O
eukaryotic O
mRNA O
is O
formed O
cotranscriptionally O
by O
the O
sequential O
action O
of O
three O
enzymes O
: O
RNA B
triphosphatase I
, O
RNA B
guanylyltransferase I
, O
and O
RNA B
( I
guanine I
- I
7 I
) I
- I
methyltransferase I
. O

Sequence O
analysis O
revealed O
that O
the O
MEMA B
protein I
is O
identical O
with O
a O
160 B
kDa I
nuclear I
' I
domain I
rich I
in I
serines I
' I
( I
DRS I
) I
protein I
occurring O
free O
in O
the O
nucleoplasm O
and O
in O
U2 B
- I
ribonucleoprotein I
structures I
. O

We O
now O
demonstrate O
that O
CCAAT B
/ I
enhancer I
- I
binding I
protein I
( I
C I
/ I
EBP I
) I
delta I
is O
a O
major O
component O
of O
a O
PGE2 O
- O
stimulated O
DNA O
- O
protein O
complex O
involving O
HS3D B
and O
find O
that O
C B
/ I
EBPdelta I
transactivates O
IGF B
- I
I I
promoter I
1 I
through O
this O
site O
. O

Polarised O
expression O
of O
human O
intestinal O
N B
- I
benzoyl I
- I
L I
- I
tyrosyl I
- I
p I
- I
aminobenzoic I
acid I
hydrolase I
( O
human B
meprin I
) O
alpha O
and O
beta O
subunits O
in O
Madin O
- O
Darby O
canine O
kidney O
cells O
. O

The O
U14 B
genes I
of O
mouse O
as O
well O
as O
rat O
, O
hamster O
, O
human O
, O
Xenopus O
and O
trout O
are O
encoded O
within O
introns O
of O
the O
constitutively O
expressed O
70 B
- I
kDa I
- I
cognate I
- I
heat I
- I
shock I
protein I
gene I
( O
hsc70 B
) O
. O

Transcription O
initiation O
sites O
of O
the O
rat O
II B
beta I
- I
, I
III I
beta I
, I
and I
O I
beta I
- I
globin I
genes O
were O
determined O
to O
be O
52 O
base O
pairs O
( O
bp O
) O
5 O
' O
- O
upstream O
of O
the O
translation O
initiation O
codon O
( O
ATG O
) O
, O
in O
each O
gene O
by O
primer O
extension O
analysis O
. O

Epstein B
- I
Barr I
virus I
- I
encoded I
latent I
membrane I
protein I
1 I
activates O
the O
JNK B
pathway O
through O
its O
extreme O
C O
terminus O
via O
a O
mechanism O
involving O
TRADD B
and O
TRAF2 B
. O

Angiotensin B
II I
induces O
nuclear B
factor I
( I
NF I
) I
- I
kappaB1 I
isoforms I
to O
bind O
the O
angiotensinogen B
gene I
acute O
- O
phase O
response O
element O
: O
a O
stimulus O
- O
specific O
pathway O
for O
NF B
- I
kappaB I
activation O
. O

Pokeweed B
mitogen I
( O
PWM B
) O
or O
anti B
- I
CD3 I
significantly O
increases O
c B
- I
jun I
messenger I
RNA I
( I
mRNA I
) I
levels O
in O
T O
cells O
. O

The O
cis O
- O
acting O
elements O
that O
control O
promoter O
activity O
include O
binding O
sites O
for O
transcription O
factors O
Sp1 B
and O
alphaCbf B
, O
a O
60 B
- I
kDa I
CCAAT I
box I
- I
binding I
protein I
. O

Mouse B
growth I
hormone I
transcription I
factor I
Zn I
- I
16 I
: O
unique O
bipartite O
structure O
containing O
tandemly O
repeated O
zinc O
finger O
domains O
not O
reported O
in O
rat B
Zn I
- I
15 I
. O

taurocholate I
cotransporter I
protein I
and O
organic B
anion I
transporter I
protein I
1 I
. O

Previously O
, O
we O
reported O
that O
scanthrough O
translation O
, O
where O
the O
initiating O
AUG O
of O
a O
primary O
open O
reading O
frame O
is O
bypassed O
, O
is O
most O
likely O
to O
account O
for O
the O
presentation O
of O
cryptic O
epitopes O
from O
alternative O
reading O
frames O
within O
the O
influenza B
A I
PR I
/ I
8 I
/ I
34 I
nucleoprotein I
gene I
. O

Several O
mutations O
disrupted O
the O
endonuclease O
and O
helicase B
activities O
; O
however O
, O
only O
one O
amino B
- I
terminal I
- I
charge I
cluster I
mutant I
protein I
( O
D40A O
- O
D42A O
- O
D44A O
) O
completely O
lost O
AAV O
hairpin O
DNA O
binding O
activity O
. O

We O
previously O
showed O
that O
this O
proteolysis O
1 O
) O
can O
be O
acutely O
promoted O
by O
the O
phorbol O
ester O
phorbol O
12 O
- O
myristate O
13 O
- O
acetate O
( O
PMA O
) O
, O
2 O
) O
requires O
a O
metalloprotease B
activity O
, O
3 O
) O
generates O
both O
shed O
GHBP B
and O
a O
membrane B
- I
associated I
GHR I
transmembrane I
/ I
cytoplasmic I
domain I
remnant O
, O
and O
4 O
) O
results O
in O
down O
- O
regulation O
of O
GHR B
abundance O
and O
GH B
signaling O
. O

The O
TraD B
protein I
( I
83 I
, I
899 I
Da I
) I
contains O
three O
hydrophobic O
regions O
, O
of O
which O
two O
are O
located O
near O
the O
amino O
- O
terminal O
region O
. O

UDP B
- I
GlcNAc I
: O
alpha B
- I
6 I
- I
D I
- I
mannoside I
beta I
- I
1 I
, I
2 I
- I
N I
- I
acetylglucosaminyltransferase I
II I
( O
GnT B
II I
; O
EC B
2 I
. I
4 I
. I
1 I
. I
143 I
) O
is O
essential O
for O
the O
normal O
assembly O
of O
complex O
Asn O
- O
linked O
glycans O
. O

UDP B
- I
GlcNAc I
: O
alpha B
- I
6 I
- I
D I
- I
mannoside I
beta I
- I
1 I
, I
2 I
- I
N I
- I
acetylglucosaminyltransferase I
II I
( O
GnT B
II I
; O
EC B
2 I
. I
4 I
. I
1 I
. I
143 I
) O
is O
essential O
for O
the O
normal O
assembly O
of O
complex O
Asn O
- O
linked O
glycans O
. O

Processing O
, O
secretion O
, O
and O
immunoreactivity O
of O
carboxy B
terminally I
truncated I
dengue I
- I
2 I
virus I
envelope I
proteins I
expressed O
in O
insect O
cells O
by O
recombinant O
baculoviruses O
. O

A O
polymorphic O
bipartite O
motif O
signals O
nuclear O
targeting O
of O
early O
auxin O
- O
inducible O
proteins O
related O
to O
PS B
- I
IAA4 I
from I
pea I
( I
Pisum I
sativum I
) I
. O

When O
ligated O
to O
the O
proIL B
- I
1 I
beta I
cap I
site I
- I
proximal I
region I
( O
located O
between O
- O
131 O
to O
+ O
12 O
) O
, O
both O
the O
proIL B
- I
1 I
beta I
and O
the O
simian B
virus I
40 I
enhancer I
elements I
functioned O
more O
efficiently O
in O
monocytes O
than O
in O
HeLa O
cells O
, O
which O
are O
not O
normally O
competent O
for O
IL B
- I
1 I
beta I
expression O
. O

Molecular O
cloning O
and O
expression O
of O
human B
UDP I
- I
d I
- I
Xylose I
: I
proteoglycan I
core I
protein I
beta B
- I
d I
- I
xylosyltransferase I
and O
its O
first O
isoform B
XT I
- I
II I
. O

We O
have O
previously O
identified O
, O
by O
screening O
a O
lambda O
gt11 O
expression O
library O
, O
murine B
protein I
mXBP I
, O
which O
binds O
to O
a O
sequence O
which O
overlaps O
the O
3 O
' O
end O
of O
the O
murine B
class I
II I
major I
histocompatibility I
complex I
A I
alpha I
gene I
X I
box I
, O
a O
conserved O
transcription O
element O
found O
upstream O
of O
all O
class O
II O
genes O
. O

The O
results O
suggest O
that O
GATA B
- I
5 I
may O
have O
specific O
downstream O
targets O
and O
that O
GATA B
- I
4 I
, I
- I
5 I
, I
and I
- I
6 I
can O
only O
partially O
substitute O
for O
each O
other O
in O
cardiogenesis O
. O

Molecular O
cloning O
of O
a O
novel O
human B
I I
- I
mfa I
domain I
- I
containing I
protein I
that O
differently O
regulates O
human O
T O
- O
cell O
leukemia O
virus O
type O
I O
and O
HIV O
- O
1 O
expression O
. O

O B
. I
novo I
- I
ulmi I
RNA I
- I
7 I
, O
previously O
believed O
to O
be O
a O
satellite O
- O
like O
RNA O
, O
is O
shown O
to O
be O
a O
defective O
RNA O
, O
derived O
from O
OnuMV4 B
- I
Ld I
RNA I
by O
multiple O
internal O
deletions O
. O

Here O
we O
describe O
an O
in O
vitro O
assay O
where O
the O
NS3 B
- I
4A I
polyprotein I
, O
NS3 B
, O
the O
serine B
proteinase I
domain I
( I
the I
N I
- I
terminal I
181 I
residues I
of I
NS3 I
) I
, O
and O
the O
NS4A B
cofactor I
were O
produced O
by O
cell O
- O
free O
translation O
and O
tested O
for O
trans O
- O
processing O
of O
radiolabeled O
substrates O
. O

CCAAT B
/ I
enhancer I
- I
binding I
protein I
isoforms I
beta I
and I
delta I
are O
expressed O
in O
mammary O
epithelial O
cells O
and O
bind O
to O
multiple O
sites O
in O
the O
beta B
- I
casein I
gene I
promoter I
. O

Hormonal O
regulation O
of O
multiple O
promoters O
of O
the O
rat B
mitochondrial I
glycerol I
- I
3 I
- I
phosphate I
dehydrogenase I
gene I
: O
identification O
of O
a O
complex O
hormone O
- O
response O
element O
in O
the O
ubiquitous O
promoter O
B O
. O

We O
describe O
the O
identification O
and O
initial O
characterization O
of O
neurobeachin B
, O
a O
neuron O
- O
specific O
multidomain O
protein O
of O
327 O
kDa O
with O
a O
high O
- O
affinity O
binding O
site O
( O
K O
( O
d O
) O
, O
10 O
nm O
) O
for O
the O
type B
II I
regulatory I
subunit I
of I
protein I
kinase I
A I
( O
PKA B
RII I
) O
. O

D5 B
/ I
D1 I
( I
CT I
) I
or O
D5 B
/ I
D1D I
( I
CT I
) I
tail O
substitution O
mutants O
displayed O
a O
rank O
order O
of O
potency O
and O
agonist O
affinities O
virtually O
mimicking O
wild B
- I
type I
( I
wt I
) I
D1 I
receptors I
, O
as O
indexed O
by O
both O
ligand O
binding O
and O
dopamine O
- O
stimulated O
cAMP O
accumulation O
assays O
, O
and O
, O
similar O
to O
wt O
D1 B
receptors I
, O
did O
not O
exhibit O
receptor O
constitutive O
activity O
or O
responsiveness O
to O
inverse O
agonists O
. O

However O
, O
primary O
transcripts O
of O
a O
variant B
tRNA I
( I
Val I
) I
( I
UAC I
) I
gene I
are O
processing O
deficient O
under O
standard O
growth O
conditions O
( O
30 O
degrees O
C O
) O
, O
due O
to O
a O
slightly O
altered O
5 O
' O
flanking O
region O
. O

The O
binding O
of O
transcription O
factor O
AP B
- I
1 I
and O
vitamin B
D I
receptor I
( O
VDR B
) O
to O
the O
composite O
AP B
- I
1 I
plus I
vitamin I
- I
D I
- I
responsive I
promoter I
region O
( O
AP B
- I
1 I
+ I
VDRE I
) O
of O
the O
human B
osteocalcin I
gene I
was O
characterized O
in O
osteocalcin B
- O
producing O
( O
MG O
- O
63 O
) O
and O
non O
- O
producing O
( O
U2 O
- O
Os O
, O
SaOs O
- O
2 O
) O
human O
osteosarcoma O
cell O
lines O
. O

Genomic O
DNA O
clones O
containing O
the O
T B
- I
cell I
- I
specific I
human I
MAL I
gene I
were O
isolated O
. O

In O
contrast O
, O
exogenous B
PTHrP1 I
- I
34 I
and I
1 I
- I
86 I
peptides I
did O
not O
significantly O
affect O
IL B
- I
8 I
production O
; O
moreover O
, O
PTHrP B
- I
neutralizing I
antibodies I
did O
not O
inhibit O
the O
production O
of O
IL B
- I
8 I
by O
transfected O
PTHrP B
. O

Tryptic O
cleavage O
and O
peptide O
sequence O
analysis O
demonstrated O
that O
the O
98 O
- O
kD O
protein O
is O
identical O
to O
a O
recently O
cloned O
protein O
, O
special B
A I
- I
T I
- I
rich I
binding I
protein I
1 I
( O
SATB1 B
) O
, O
that O
binds O
selectively O
to O
nuclear O
matrix O
/ O
scaffold O
- O
associated O
regions O
of O
DNA O
( O
MARs O
/ O
SARs O
) O
. O

Toward O
this O
end O
, O
we O
prepared O
synthetic O
proteins O
with O
either O
the O
catalytic O
domain O
of O
FAP B
- I
1 I
( I
C I
- I
terminal I
399 I
amino I
acids I
) I
or O
its O
inactive O
form O
( O
Cys2408 O
- O
- O
> O
Ser O
) O
fused O
to O
glutathione B
- I
S I
- I
transferase I
( O
GST B
) O
. O

Transcriptional O
regulation O
of O
the O
mouse B
cytosolic I
chaperonin I
subunit I
gene I
Ccta B
/ I
t I
- I
complex I
polypeptide I
1 I
by O
selenocysteine B
tRNA I
gene I
transcription I
activating I
factor I
family I
zinc I
finger I
proteins I
. O

Ras B
- I
and I
ultra I
- I
violet I
- I
responsive I
protein I
kinases I
that O
phosphorylate O
c B
- I
Jun I
on O
serine O
residues O
at O
positions O
63 O
and O
73 O
and O
stimulate O
its O
transcriptional O
activity O
have O
been O
identified O
. O

ENV B
also O
was O
secreted O
from O
P O
. O
pastoris O
using O
the O
S B
. I
cerevisiae I
alpha I
- I
factor I
prepro I
secretion I
leader I
and O
the O
S B
. I
cerevisiae I
invertase I
signal I
sequence I
. O

The O
coding O
sequences O
of O
the O
Crry B
gene I
encompass O
over O
25 O
kb O
of O
DNA O
, O
whereas O
the O
Crry B
- O
ps B
sequences O
are O
included O
within O
a O
single O
5 B
. I
6 I
- I
kb I
Eco I
- I
R1 I
fragment I
. O

Genes O
for O
ocs B
element I
binding I
factors I
( O
OBFs B
) O
, O
belonging O
to O
a O
specific O
class O
of O
basic B
- I
region I
leucine I
zipper I
( I
bZIP I
) I
transcription I
factors I
, O
have O
been O
isolated O
in O
a O
number O
of O
plants O
. O

The O
pel B
gene I
from O
an O
Amycolata O
sp O
. O
encoding O
a O
pectate B
lyase I
( O
EC B
4 I
. I
2 I
. I
2 I
. I
2 I
) O
was O
isolated O
by O
activity O
screening O
a O
genomic O
DNA O
library O
in O
Streptomyces O
lividans O
TK24 O
. O

We O
have O
cloned O
and O
sequenced O
the O
mouse B
NMO1 I
cDNA I
, O
which O
encodes O
the O
NAD B
( I
P I
) I
H I
: I
menadione I
oxidoreductase I
[ O
also O
called O
NAD B
( I
P I
) I
H I
: I
( I
quinone I
acceptor I
) I
oxidoreductase I
; O
quinone B
reductase I
; O
azo B
dye I
reductase I
; O
DT B
diaphorase I
; O
EC B
1 I
. I
6 I
. I
99 I
. I
2 I
] O
. O

We O
have O
cloned O
and O
sequenced O
the O
mouse B
NMO1 I
cDNA I
, O
which O
encodes O
the O
NAD B
( I
P I
) I
H I
: I
menadione I
oxidoreductase I
[ O
also O
called O
NAD B
( I
P I
) I
H I
: I
( I
quinone I
acceptor I
) I
oxidoreductase I
; O
quinone B
reductase I
; O
azo B
dye I
reductase I
; O
DT B
diaphorase I
; O
EC B
1 I
. I
6 I
. I
99 I
. I
2 I
] O
. O

We O
have O
cloned O
and O
sequenced O
the O
mouse B
NMO1 I
cDNA I
, O
which O
encodes O
the O
NAD B
( I
P I
) I
H I
: I
menadione I
oxidoreductase I
[ O
also O
called O
NAD B
( I
P I
) I
H I
: I
( I
quinone I
acceptor I
) I
oxidoreductase I
; O
quinone B
reductase I
; O
azo B
dye I
reductase I
; O
DT B
diaphorase I
; O
EC B
1 I
. I
6 I
. I
99 I
. I
2 I
] O
. O

